Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000166482 | SCV000217281 | likely benign | Hereditary cancer-predisposing syndrome | 2014-10-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000227287 | SCV000282981 | likely benign | Ataxia-telangiectasia syndrome | 2025-01-08 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000166482 | SCV000682253 | likely benign | Hereditary cancer-predisposing syndrome | 2016-11-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001721081 | SCV000716015 | likely benign | not provided | 2020-07-20 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000166482 | SCV002527878 | likely benign | Hereditary cancer-predisposing syndrome | 2020-09-03 | criteria provided, single submitter | curation | |
Myriad Genetics, |
RCV004589795 | SCV005083474 | benign | Familial cancer of breast | 2024-05-22 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |